Carter's (CRI) PT Lowered to $100 at Monness, Crespi, Hardt
Tweet
Share
E-mailGet Alerts CRI Hot Sheet
Price: $32.28 -3.79%
Rating Summary:
10 Buy, 10 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
10 Buy, 10 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
Monness, Crespi, Hardt analyst Jim Cartier lowered the price target on Carter's (NYSE: CRI) to $100.00 (from $115.00) while maintaining a Buy rating.
You May Also Be Interested In
- BMO Capital Starts Carter's (CRI) at Outperform
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
- Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
